rs121918397
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PP3_StrongPP5_Moderate
The NM_000041.4(APOE):c.488G>A(p.Arg163His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000712 in 1,405,464 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000071 ( 0 hom. )
Consequence
APOE
NM_000041.4 missense
NM_000041.4 missense
Scores
2
7
10
Clinical Significance
Conservation
PhyloP100: 0.869
Genes affected
APOE (HGNC:613): (apolipoprotein E) The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. [provided by RefSeq, Jun 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PM1
In a helix (size 31) in uniprot entity APOE_HUMAN there are 6 pathogenic changes around while only 1 benign (86%) in NM_000041.4
PP3
MetaRNN computational evidence supports a deleterious effect, 0.949
PP5
Variant 19-44908784-G-A is Pathogenic according to our data. Variant chr19-44908784-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 17865.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APOE | NM_000041.4 | c.488G>A | p.Arg163His | missense_variant | 4/4 | ENST00000252486.9 | NP_000032.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APOE | ENST00000252486.9 | c.488G>A | p.Arg163His | missense_variant | 4/4 | 1 | NM_000041.4 | ENSP00000252486 | P1 | |
APOE | ENST00000425718.1 | c.488G>A | p.Arg163His | missense_variant | 3/3 | 1 | ENSP00000410423 | |||
APOE | ENST00000434152.5 | c.566G>A | p.Arg189His | missense_variant | 4/4 | 2 | ENSP00000413653 | |||
APOE | ENST00000446996.5 | c.488G>A | p.Arg163His | missense_variant | 4/4 | 2 | ENSP00000413135 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000648 AC: 1AN: 154258Hom.: 0 AF XY: 0.0000118 AC XY: 1AN XY: 84626
GnomAD3 exomes
AF:
AC:
1
AN:
154258
Hom.:
AF XY:
AC XY:
1
AN XY:
84626
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000712 AC: 10AN: 1405464Hom.: 0 Cov.: 33 AF XY: 0.0000101 AC XY: 7AN XY: 694802
GnomAD4 exome
AF:
AC:
10
AN:
1405464
Hom.:
Cov.:
33
AF XY:
AC XY:
7
AN XY:
694802
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Familial type 3 hyperlipoproteinemia Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 1990 | - - |
Lipoprotein glomerulopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | 3billion | May 22, 2022 | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.64; 3Cnet: 0.00). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with APOE related disorder (ClinVar ID: VCV000017865 / PMID: 15256764). Different missense changes at the same codon (p.Arg163Cys, p.Arg163Pro) have been reported to be associated with APOE related disorder (ClinVar ID: VCV000017851, VCV000017879 / PMID: 3243553, 9176854). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T;T;T
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;.;.;.
MutationTaster
Benign
N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;.;D
REVEL
Uncertain
Sift
Benign
T;T;.;T
Sift4G
Benign
T;T;T;T
Polyphen
P;.;.;.
Vest4
MutPred
Loss of solvent accessibility (P = 0.1077);Loss of solvent accessibility (P = 0.1077);.;Loss of solvent accessibility (P = 0.1077);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at